eMedicine Specialties > Emergency Medicine > Environmental

Fire Ant Bites

Author: James P Ralston, MD, President, Dermatology Center of McKinney
Coauthor(s): Ronald P Rapini, MD, Professor and Chair, Department of Dermatology, Professor of Pathology, University of Texas Medical School at Houston, MD Anderson Cancer Center
Contributor Information and Disclosures

Updated: Jun 11, 2007

Introduction

Background

The fire ant is a wingless member of the order Hymenoptera, which includes wasps and bees. It is a potentially lethal environmental hazard in the United States, infesting more than 310 million acres of land. Fire ants are resistant to control efforts and can overwhelm an environment. They damage farm equipment, electrical systems, irrigation systems, and land. They build mounds in sunny, open areas (eg, lawns, playgrounds, parks, golf courses) and aggressively attack anyone who disrupts their mound.

Fire ants are thought to have arrived in the United States between 1918 and the 1930s from South America by ships that docked in Mobile, Alabama. They are now found throughout the Southeast and are migrating rapidly. One contributing factor to this expansion is progressive urbanization in the United States, which creates the type of disturbed habitat that the fire ants prefer. Their mobility and ability to establish colonies in diverse habitats makes the detection of new infestations difficult. Sometimes, colonies exist several years before detection.

Each year, fire ants sting more than one half of the population in endemic areas of the Southeast. They cause a variety of medical problems, including increasing numbers of hypersensitivity reactions, secondary infections, neurologic complications, and even death.

Pathophysiology

The fire ant uses its mandibles to grasp its victim. It arches its body and drives an abdominal stinger into the skin to release venom. If not quickly removed, it then pivots around its mandibles and inflicts further stings in a circular pattern.

The stinger is a modified ovipositor that consists of a dorsal stylet and 2 ventrolateral lancets. These structures surround the venom canal, which connects to the venom sac. A pair of coiled glands produces the venom that discharges into the venom sac.

Fire ant venom differs from bee and wasp venom, which are mostly proteinaceous solutions. About 95% of fire ant venom is water-insoluble, is nonproteinaceous, and contains dialkylpiperidine hemolytic factors. These hemolytic factors induce the release of histamine and other vasoactive amines from mast cells, resulting in a sterile pustule at the sting site. These alkaloids are not immunogenic, but their toxicity to the skin is believed to cause the pustules to form.

The venom also contains several allergenic proteins, measuring about 1.5% by dry weight. Four major allergenic proteins exist; Soli 1-4 induce immunoglobulin E (IgE) responses, including anaphylaxis, in patients who are allergic. Antigenic similarity exists between these proteins and bee and wasp venoms.

Many patients have venom-specific IgE-mediated wheal and flare reactions that develop over hours into pruritic edematous, indurated, and erythematous lesions that persist for up to 72 hours. These lesions may involve an entire extremity. They histologically resemble late-phase mast cell–dependent reactions and show an infiltrate of eosinophils, neutrophils, and fibrin deposition. Large, local reactions rarely can cause edematous tissue compression, leading to vascular compromise of an extremity.

Frequency

United States

Because most fire ant stings are not severe enough to cause the victim to seek medical attention, estimating the frequency of stings is difficult; however, annually, more than one half of the population in endemic areas is stung, and the incidence appears to be increasing.

Mortality/Morbidity

Fire ants are becoming an increasingly important public health concern in the United States. More than 80 fatalities have been reported from fire ant-induced anaphylaxis.

Race

Fire ant stings may occur in people of any race. No race has been shown to have an increased risk of being stung or to have a higher predisposition to complications.

Sex

Fire ants sting both males and females without discrimination.

Age

Fire ants sting people of all ages, but children are overrepresented, probably because of greater environmental exposure.

Clinical

History

  • Fire ants can inflict several painful burning stings within seconds.
  • The severity of symptoms varies with the size of the ant and the allergic response of the patient.
  • Patients often present with a history of an immediate intense burning sensation (the "fire" associated with the ant's name) and itching at the sting site.
  • Stings occurring during the winter months are often less severe and may go unnoticed until a local reaction develops. This reflects the seasonal variation in venom protein concentration.

Physical

Physical findings from fire ant bites and stings can be subdivided into local and systemic reactions.

  • Local reactions
    • Skin lesions produced by fire ants typically occur in clusters.
    • The attachment site of the ant's mandibles makes 2 small, hemorrhagic puncta.
    • The initial reaction to the sting is the development of a wheal, followed within 24 hours by a sterile vesicle.
    • The fluid in the vesicle becomes cloudy; after 8-10 hours, the typical lesion is an umbilicated, sterile pustule on a red, edematous base.
    • The pustule may last for several days and is characteristic for fire ant stings.
    • The pustule then ruptures, forms a crust, and heals several days later, sometimes leaving small scars.
    • Excoriation and open erosions may lead to secondary infection.
  • Systemic reactions
    • Systemic reactions range from skin manifestations (eg, generalized urticaria, angioedema, pruritus, erythema) to potentially life-threatening bronchospasm, laryngeal edema, or hypotension.
    • Anaphylaxis may occur immediately or hours after a sting. These reactions are similar to those caused by venom of other Hymenoptera insects, except for the characteristic pustule.
    • Seizures, mononeuritis, serum sickness, nephrotic syndrome, and worsening of preexisting cardiopulmonary disease have also occurred.
    • The reactions may increase in severity with successive attacks, and fatal allergic reactions are becoming more common.

Causes

The fire ant prefers open, sunny areas, such as pastures, parks, lawns, playgrounds, golf courses, and fields. Colonies also occur in or around buildings. Mound building increases considerably during warm months of the year when soil is moist. Concentrations in some areas exceed 200 mounds per acre. Several risk factors have been identified:

  • Immobility
    • Infants and elderly persons have an increased risk of fire ant stings, as do others with decreased mobility or an inability to defend themselves, such as persons who are inebriated and fall asleep on or near a mound.
    • Massive sting attacks by fire ants have occurred in nursing home residents.
    • Infants are unable to defend themselves from attacks.
    • Immobilized people are likely to have numerous stings when exposed to fire ants.
    • In these situations, determining the source of the fire ants and exterminating them are essential.
  • Diabetes mellitus
    • Persons with diabetes are at an increased risk of secondary infection of a sting site because of potential circulatory or neurosensory compromise of the extremities.
    • Secondary infection of a sting site may lead to pyoderma or sepsis.
  • Alcoholism
    • Several cases of severe fire ant stings have been reported in people who are alcoholics, often secondary to alcohol-induced unconsciousness.
    • One case involved a person with alcoholism who fell asleep in a ditch and apparently used a fire ant mound as a pillow. He was hospitalized hours later with about 5000 pustules from fire ant stings on his face, trunk, and extremities that eventually healed with scarring.
  • Previous sensitization
    • Systemic reactions typically occur in patients previously sensitized to fire ant stings.
    • Individuals with no previous exposure can have anaphylactic reactions after their first sting. Most of these patients are previously sensitized to yellow jacket venom.

More on Fire Ant Bites

Overview: Fire Ant Bites
Differential Diagnoses & Workup: Fire Ant Bites
Treatment & Medication: Fire Ant Bites
Follow-up: Fire Ant Bites
Multimedia: Fire Ant Bites
References

References

  1. Burroughs R, Elston DM. What's eating you? Fire ants. Cutis. Feb 2005;75(2):85-9. [Medline].

  2. Champion RH, Burton JL, Burns DA. Rook/Wilkinson/Ebling Textbook of Dermatology. Vol 2. 6th ed. London, England: Blackwell Science; 1998:1436-7.

  3. Cotran RS, Kumar V, Collins T, eds. Robbins Pathologic Basis of Disease. 6th ed. Philadelphia, Pa: WB Saunders; 1999:1212.

  4. Dambro MR, Griffith JA. Griffith's 5-Minute Clinical Consult. Philadelphia, Pa: Lippincott Williams & Wilkins; 1999:570-1.

  5. Ellis AK, Day JH. Clinical reactivity to insect stings. Curr Opin Allergy Clin Immunol. Aug 2005;5(4):349-54. [Medline].

  6. Ford JL, Dolen WK, Feger TA, Hoffman DR, Stafford CT. Evaluation of an in vitro assay for fire ant venom-specific IgE. J Allergy Clin Immunol. Sep 1997;100(3):425-7. [Medline].

  7. Freedberg IM, Eisen AZ, Wolff K, eds. Fitzpatrick's Dermatology in General Medicine. Vol 2. 5th ed. New York, NY: McGraw-Hill; 1999:2693-5.

  8. Goddard J, Jarratt J, de Castro FR. Evolution of the fire ant lesion. JAMA. Nov 1 2000;284(17):2162-3. [Medline].

  9. Hoffman DR. Reactions to less common species of fire ants. J Allergy Clin Immunol. Nov 1997;100(5):679-83. [Medline].

  10. Jerrard DA. ED management of insect stings. Am J Emerg Med. Jul 1996;14(4):429-33. [Medline].

  11. Kemp SF, deShazo RD, Moffitt JE, Williams DF, Buhner WA. Expanding habitat of the imported fire ant (Solenopsis invicta): a public health concern. J Allergy Clin Immunol. Apr 2000;105(4):683-91. [Medline].

  12. Lee TH, Comes S, Burgos T. ePocrates qRx. ePocrates Inc. Available at http://www.epocrates.com/. Accessed 2000.

  13. Odom RB, James WD, Berger TG. Andrews' Diseases of the Skin: Clinical Dermatology. 9th ed. Philadelphia, Pa: WB Saunders; 2000:559.

  14. Ownby DR. Pediatric anaphylaxis, insect stings, and bites. Immunol Allergy Clin North Am. 1999;19 (2):347-61.

  15. Portnoy JM, Moffitt JE, Golden DB, Bernstein WE, Dykewicz MS, Fineman SM, et al. Stinging insect hypersensitivity: a practice parameter. The Joint Force on Practice Parameters, the American Academy of Allergy, Asthma and Immunology, the American College of Allergy, Asthma and Immunology, and the Joint Council of Allergy, Asthma and Immunology. J Allergy Clin Immunol. May 1999;103(5 Pt 1):963-80. [Medline].

  16. Rakel RE. Conn's Current Therapy 2000. 52nd ed. Philadelphia, Pa: WB Saunders; 2000:753-5.

  17. Smith KE, Fenske NA. Cutaneous manifestations of alcohol abuse. J Am Acad Dermatol. Jul 2000;43(1 Pt 1):1-16; quiz 16-8. [Medline].

  18. Williams DF, deShazo RD. Biological control of fire ants: an update on new techniques. Ann Allergy Asthma Immunol. Jul 2004;93(1):15-22. [Medline].

Further Reading

Keywords

Solenopsis invicta, S invicta, Solenopsis richteri, S richteri, Solenopsis saevissima, S saevissima, Solenopsis geminata, S geminata, Solenopsis xyloni, S xyloni, Hymenoptera, hypersensitivity reactions, secondary infections, dialkylpiperidine hemolytic factors, allergenic proteins, Soli 1-4, anaphylaxis, anaphylactic reaction, fireant-induced anaphylaxis, hemorrhagic puncta, generalized urticaria, angioedema, pruritus, erythema, seizures, mononeuritis, serum sickness, nephrotic syndromesepsis, alcohol-induced unconsciousness

Contributor Information and Disclosures

Author

James P Ralston, MD, President, Dermatology Center of McKinney
James P Ralston, MD is a member of the following medical societies: American Academy of Dermatology, American Medical Association, American Society for Dermatologic Surgery, and Texas Medical Association
Disclosure: Nothing to disclose.

Coauthor(s)

Ronald P Rapini, MD, Professor and Chair, Department of Dermatology, Professor of Pathology, University of Texas Medical School at Houston, MD Anderson Cancer Center
Ronald P Rapini, MD is a member of the following medical societies: American Academy of Dermatology, American Dermatological Association, American Medical Association, American Society for Dermatologic Surgery, American Society for MOHS Surgery, Society for Investigative Dermatology, Southern Medical Association, and Texas Medical Association
Disclosure: Elsevier publishers Royalty Independent contractor

Medical Editor

Daniel J Hogan, MD, Clinical Professor of Internal Medicine (Dermatology), NOVA Southeastern University; Investigator, Hill Top Research, Florida Research Center
Daniel J Hogan, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Contact Dermatitis Society, and Canadian Dermatology Association
Disclosure: Nothing to disclose.

Pharmacy Editor

Michael J Wells, MD, Associate Professor, Department of Dermatology, Texas Tech University Health Sciences Center
Michael J Wells, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Medical Association, and Texas Medical Association
Disclosure: Nothing to disclose.

Managing Editor

Jeffrey J Miller, MD, Associate Professor of Dermatology, Penn State University College of Medicine; Staff Dermatologist, Penn State Milton S Hershey Medical Center
Jeffrey J Miller, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, Association of Professors of Dermatology, North American Hair Research Society, and Society for Investigative Dermatology
Disclosure: Nothing to disclose.

CME Editor

Joel M Gelfand, MD, MSCE, Medical Director, Clinical Studies Unit, Assistant Professor, Department of Dermatology, Associate Scholar, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania
Joel M Gelfand, MD, MSCE is a member of the following medical societies: Society for Investigative Dermatology
Disclosure: AMGEN Consulting fee Consulting; AMGEN Grant/research funds None; Genentech Consulting fee Consulting; Centocor Consulting fee Consulting; Centocor Grant/research funds None; Covance Consulting fee Consulting; Shire  Consulting

Chief Editor

Dirk M Elston, MD, Director, Department of Dermatology, Geisinger Medical Center
Dirk M Elston, MD is a member of the following medical societies: American Academy of Dermatology
Disclosure: Nothing to disclose.

RELATED EMEDICINE ARTICLES
 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.